JOE
HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Accepted Preprint first posted online on 7 October 2008

Journal of Endocrinology 2009;200:35.

Journal of Endocrinology (2008) In press
DOI: 10.1677/JOE-08-0340
© 2008 Society for Endocrinology
This Article
Right arrow Accepted manuscript (PDF)
Right arrow All Versions of this Article:
JOE-08-0340v1
200/1/35    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Xiaohui, W.
Right arrow Articles by Lu, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Xiaohui, W.
Right arrow Articles by Lu, J.

RESEARCH

Role of RhoB in the antiproliferative effect of glucocorticoid receptor on macrophage RAW264.7 cells

Wang Xiaohui, Yuxia Chen, Yan Wang, Xiaoyan Zhu, Yuanyuan Ma, Shiming Zhang and Jian Lu

W Xiaohui, Department of Pathophsiology, Second Military Medical University, Shanghai, China
Y Chen, Department of Pathophsiology, Second Military Medical University, Shanghai, China
Y Wang, Department of Pathophsiology, Second Military Medical University, Shanghai, China
X Zhu, Department of Pathophsiology, Second Military Medical University, Shanghai, China
Y Ma, Department of Pathophsiology, Second Military Medical University, Shanghai, China
S Zhang, Shanghai, 200433, China
J Lu, Department of Pathophysiology,, Second Military Medical University, Shanghai, China

Correspondence: Wang Xiaohui, Email: wangpan96{at}yahoo.com.cn

Abstract

Although glucocorticoid (GC) has been reported to inhibit macrophage killing activity and cytokine production in response to proinflammatory stimuli, the effect of GC on macrophage proliferation is controversial. In our previous study we found that inhibition of glucocorticoid receptor (GR) expression in murine macrophage cell line RAW267.4 cells [RAW-GR(-) cells] by RNAi significantly promoted cell proliferation. In the present study, we provide the evidence that the expression of RhoB, a member of Rho GTPases with anti-cancer character, remarkably decreased in RAW-GR(-) cells and in RAW264.7 cells transient transfected with GR-RNAi vector. Overexpression or constitutive activation of RhoB in RAW-GR(-) and RAW264.7 cells by transfection with wild type RhoB expression vector (RhoB-wt) or constitutively activated RhoB plasmid (RhoB-V14) resulted in decreased proliferation of the two cell lines. Oppositely, the proliferation of RAW264.7 cells was significantly increased when inhibited the expression of RhoB by RNA interference technique or inhibited the activity of RhoB by transfection with dominant negative RhoB mutant that is defective in nucleotide binding (RhoB-N19). In addition, enhanced activity of Akt but not ERK1/2 or p38 was found in RAW-GR(-) cells. Blocking the pathway of phosphatidylinositol 3-kinase (PI3K)/Akt with the specific inhibitor LY294002 decreased the proliferation and elevated RhoB protein level, indicating that PI3K/Akt signal plays its role of proliferation modulation in the upstream of RhoB protein. In conclusion, these results demonstrated that RhoB played an important role in the antiproliferative effect of GR on RAW264.7 cells by GR-Akt-RhoB signaling and RhoB negatively regulated the proliferation of RAW264.7 cells.







HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2008 by the Society for Endocrinology.